| 國家衛生研究院 |
2005-03-28 |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Yang, CH; Cheng, AL |
| 臺大學術典藏 |
2018-09-10T05:14:41Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh, K.H.;Lu, Y.S.;Hsu, C.H.;Lin, J.F.;Chao, H.J.;Huang, T.C.;Chung, C.Y.;Chang, C.S.;Yang, C.H.;Cheng, A.L.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2005 |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Cheng A.L.; Yang C.H.; Chang C.S.; Chung C.Y.; Huang T.C.; Chao H.J.; Lin J.F.; CHIH-HUNG HSU; Lu Y.S.; Yeh K.H.; Yeh K.H.;Lu Y.S.;Chih-Hung Hsu;Lin J.F.;Chao H.J.;Huang T.C.;Chung C.Y.;Chang C.S.;Yang C.H.;Cheng A.L. |
| 臺大學術典藏 |
2020-05-25T06:52:09Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh K.H;Yen-Shen Lu;Hsu C.H;Lin J.F;Chao H.J;Huang T.C;Chung C.Y;Chang C.S;Yang C.H;Cheng A.L.; Yeh K.H; YEN-SHEN LU; Hsu C.H; Lin J.F; Chao H.J; Huang T.C; Chung C.Y; Chang C.S; Yang C.H; Cheng A.L. |
| 臺大學術典藏 |
2021-03-10T05:34:20Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh K.H.; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Ta-Chen Huang; Chung C.Y.; Chang C.S.; Yang C.H.; Cheng A.L. |
| 臺大學術典藏 |
2021-09-01T02:02:18Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh K.H.; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Huang T.C.; Chung C.Y.; Chang C.S.; Yang C.H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-01-28T01:06:49Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Kun-Huei Yeh;Lu Y.S.;Hsu C.H.;Lin J.F.;Chao H.J.;Huang T.C.;Chung C.Y.;Chang C.S.;Yang C.H.;Cheng A.L.; KUN-HUEI YEH; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Huang T.C.; Chung C.Y.; Chang C.S.; Yang C.H.; Cheng A.L. |
| 國立臺灣大學 |
2005-06 |
Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. |
| 國立臺灣大學 |
2005-06 |
Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. |
| 國家衛生研究院 |
2000-12 |
Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer
|
Chen, YM; Perng, RP; Whang-Peng, J; Wu, HW; Lin, WC; Tsai, CM |
| 國家衛生研究院 |
2003-04 |
Phase II study with vinorelbine and cisplatin in advanced non-small cell lung cancer after failure of previous chemotherapy
|
Chen, Y;Lee, C;Lin, W;Tsai, C;Perng, R |
| 臺大學術典藏 |
2022-08-19T00:21:16Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Cheng A.-L.; Chang K.-J.; Chen M.M.; Lu Y.-S.; Bu C.-F.; CHIUN HSU; Huang C.-S.; Chao T.-Y. |
| 臺大學術典藏 |
2020-03-23T07:19:36Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Hsu C.;Chiun-Sheng Huang;Chao T.-Y.;Lu Y.-S.;Bu C.-F.;Chen M.M.;Chang K.-J.;Cheng A.-L.; Hsu C.; CHIUN-SHENG HUANG; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; Chang K.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:11Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Cheng A.-L.;Chang K.-J;Chen M.M;Bu C.-F;Yen-Shen Lu;Chao T.-Y;Huang C.-S;Hsu C; Hsu C; Huang C.-S; Chao T.-Y; YEN-SHEN LU; Bu C.-F; Chen M.M; Chang K.-J; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T02:02:25Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Hsu C.; Huang C.-S.; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; Chang K.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2022-08-12T06:28:23Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Hsu C.; Huang C.-S.; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; KING-JEN CHANG; Cheng A.-L. |
| 國立臺灣大學 |
2002 |
Phase Ii Trial Combining Paclitaxel with 24-Hour Infusion Cisplatin for Chemotherapy-Naive Patients with Locally Advanced or Metastatic Breast Carcinoma
|
許駿; 黃俊升; 張金堅; 鄭安理; HSU, CHIUN; HUANG, CHIUN-SHENG; CHANG, KING-JEN; CHENG, ANN-LII |
| 臺大學術典藏 |
2018-09-10T04:17:34Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma
|
Hsu, C.;Huang, C.-S.;Chao, T.-Y.;Lu, Y.-S.;Bu, C.-F.;Chen, M.M.;Chang, K.-J.;Cheng, A.-L.; CHIUN-SHENG HUANG; ANN-LII CHENG |
| 臺大學術典藏 |
2020-04-10T12:51:30Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma
|
Chiun Hsu;Huang C.-S.;Chao T.-Y.;Lu Y.-S.;Bu C.-F.;Chen M.M.;Chang K.-J.;Cheng A.-L.; Chiun Hsu; Huang C.-S.; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; Chang K.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:06Z |
Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer
|
Chua D.T.T.; Yiu H.H.-Y.; Seetalarom K.; Ng A.W.-Y.; Kurnianda J.; Shotelersuk K.; Krishnan G.; RUEY-LONG HONG; Yang M.-H.; Wang C.-H.; Sze W.-K.; Ng W.-T. |
| 國立臺灣大學 |
2009 |
Phase Ii Trial of Carboplatin and Distearoylphosphatidylcholine Pegylated Liposomal Doxorubicin (Lipo-Dox) in Recurrent Platinum-Sensitive Ovarian Cancer Following Front-Line Therapy with Paclitaxel and Platinum
|
蕭聖謀; 陳祈安; 林鶴雄; 謝長堯; 魏凌鴻; HSIAO, SHENG-MOU; CHEN, CHI-AN; LIN, HO-HSIUNG; HSIEH, CHANG-YAO; WEI, LIN-HUNG |
| 臺大學術典藏 |
2020-01-22T07:50:43Z |
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox?) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
|
Hsiao S.-M.; CHI-AN CHEN; Lin H.-H.; Hsieh C.-Y.; Wei L.-H. |
| 臺大學術典藏 |
2020-02-17T08:51:02Z |
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox?) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
|
Hsiao S.-M; Chen C.-A; HO-HSIUNG LIN; Hsieh C.-Y; Wei L.-H. |
| 臺大學術典藏 |
2020-11-27T08:14:22Z |
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox?) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
|
Hsiao S.-M.; Chen C.-A.; Lin H.-H.; CHANG-YAO HSIEH; Wei L.-H. |
| 臺大學術典藏 |
2021-03-03T03:01:14Z |
Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox?) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum
|
Hsiao S.-M.;Chen C.-A.;Ho-Hsiung Lin;Hsieh C.-Y.;Wei L.-H.; Hsiao S.-M.; Chen C.-A.; HO-HSIUNG LIN; Hsieh C.-Y.; Wei L.-H. |
